Annex III Entry 364 03/10/2023

Pelargonium Graveolens Flower Oil

Pelargonium graveolens oil

Pelargonium Graveolens Flower Oil is listed in Annex III and may only be used under the conditions shown in this record.

Restricted substance— Annex III, EU Regulation 1223/2009
Entry: 364

Record details

Other restrictions

The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: — 0,001 % in leave-on products — 0,01 % in rinse-off products.

INCI glossary name

Pelargonium Graveolens Flower Oil

Chemical name

Pelargonium graveolens oil

Regulatory information

Key data

Inventory links for Pelargonium Graveolens Flower Oil

Direct matches are limited for this record, so nearby entries from Annex III are shown as well.

Annex III 361
Nearby record in the same annex

Mentha Piperita Oil

CAS: 8006-90-4/ 84082-70-2
EC: -/ 282-015-4
Annex III 367
Nearby record in the same annex

Santalum Album Oil

CAS: 8006-87-9/ 84787-70-2
EC: 8006-87-9/ 84787-70-2
Annex III 359
Nearby record in the same annex

Laurus Nobilis Leaf Oil

CAS: 8002-41-3/ 8007-48-5/ 84603-73-6
EC: -/-/ 283-272-5
Annex III 369
Nearby record in the same annex

Geranyl Acetate

CAS: 105-87-3
EC: 203-341-5

What Annex III means for Pelargonium Graveolens Flower Oil

Pelargonium Graveolens Flower Oil is a restricted substance under Annex III of EU Cosmetics Regulation 1223/2009. Its use in cosmetics is only permitted under the specific conditions set out in the entry above, including applicable concentration limits, product type restrictions and required warning statements.

When including this substance in a formulation, all conditions — maximum concentration, product scope and warning labels — must be met simultaneously. Compliance with one condition does not override the others.

This record is linked to 15 CosIng inventory ingredients for name and identifier cross-reference. The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.

Compliance checklist

  • Document conditions of use in the Product Information File (PIF).

Frequently asked questions

Pelargonium Graveolens Flower Oil is listed in Annex III of EU Regulation 1223/2009 as a restricted substance. It may only be used under the conditions specified in the entry, including any maximum concentration, product type limitation and required warning statements shown above.

CAS 90082-51-2/ 8000-46-2 is the unique numerical identifier assigned to Pelargonium Graveolens Flower Oil by the Chemical Abstracts Service. In cosmetic compliance work, the CAS number is used to cross-reference the substance across regulatory databases, raw material specifications and safety assessment reports. Multiple EU annex entries may share the same CAS number if the same substance appears under different conditions or in different annexes.

Use the INCI Checker tool on this site to paste your full ingredient list (INCI) and scan it against all Annex II–VI entries. The tool highlights any ingredients that match restricted, prohibited or allergen-flagged records. This is useful for rapid compliance screening of finished product formulas or raw material declarations.

Source note for Annex III record Pelargonium Graveolens Flower Oil

This page summarizes one Annex III record for Pelargonium Graveolens Flower Oil from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.

Use this record page to review Annex III conditions for Pelargonium Graveolens Flower Oil, but confirm any final regulatory decision against the current official annex wording and source files.

Tools & next steps

Check your formula

Paste a full INCI list to detect Pelargonium Graveolens Flower Oil and other flagged EU annex records in one pass.

INCI Checker

Compare entries

Compare Pelargonium Graveolens Flower Oil side by side with another annex record to review differences in restrictions, concentrations and annex placement.

Compare

Browse the annex

See all records in Annex III and compare regulatory conditions across substances in this annex.

Open Annex III